Diagnosis and management of inhibitors: the need for professional collaboration

1. Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10(4): 622-31. doi: 10.1111/j.1538-7836.2012.04654.x.Search in Google Scholar

2. Baudo F, Collins P, Huth-Kühne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120(1): 39-46. doi: 10.1182/blood-2012-02-408930.Search in Google Scholar

3. Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012; 120(1): 47-55. doi: 10.1182/blood-2012-02-409185Search in Google Scholar

4. Tengborn L, Baudo F, Huth-Kühne A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG 2012; 119(12): 1529-37. doi: 10.1111/j.1471-0528.2012.03469.x.Search in Google Scholar

5. van den Berg HM, Gouw SC, van der Bom JG, et al. Factor VIII products and inhibitors in severe hemophilia A. N Engl J Med 2013; 368(15): 1457. doi: 10.1056/NEJMc1301995.Search in Google Scholar

6. Collins PW, Palmer BP, Chalmers EA, et al. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood 2014; 124(23): 3389-97. doi: 10.1182/blood-2014-07-580498.Search in Google Scholar

7. Calvez T, Chambost H, Claeyssens-Donadel S, et al. Recombinant factor VIII products and inhibitor development in previously untreated boys with severeSearch in Google Scholar

hemophilia A. Blood 2014; 124(23): 3398-408. doi: 10.1182/blood-2014-07-586347.Search in Google Scholar